COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 2224: Articles 22231-22240  | Next

Impacts of the COVID-19 epidemic on the department of stomatology in a tertiary hospital: a case study in the General Hospital of the Central Theater Command, Wuhan, China
Dong, Q., Kuria, A., Weng, Y., Liu, Y., Cao, Y.
10.1101/2020.09.11.20192450 — Posted: 2020-09-11
Mathematical Modeling and a Month Ahead Forecast of the Coronavirus Disease 2019 (COVID-19) Pandemic: An Indian Scenario
Ganiny, S., Nisar, O.
10.1101/2020.09.10.20192195 — Posted: 2020-09-11
Novel Coronavirus (COVID-19) health awareness among the United Arab Emirates Population
Qubais, B., Elbarazi, I., Barakat, M.
10.1101/2020.09.10.20191890 — Posted: 2020-09-11
How to Make COVID-19 Contact Tracing Apps work: Insights From Behavioral Economics
Ayres, I., Romano, A., Sotis, C.
10.1101/2020.09.09.20191320 — Posted: 2020-09-11
CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: Implications for disease control and prevention
Guo, H., Guo, E.
10.1101/2020.09.10.290841 — Posted: 2020-09-10
COVID-19 Biomarkers in research: Extension of the OncoMX cancer biomarker data model to capture biomarker data from other diseases.
Gogate, N., Lyman, D., Crandall, K. A., Kahsay, R., Natale, D. A., Sen, S., Mazumder, R.
10.1101/2020.09.09.196220 — Posted: 2020-09-10
Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles
Lu, M., Uchil, P. D., Li, W., Zheng, D., Terry, D. S., Gorman, J., Shi, W., Zhang, B., Zhou, T., Ding, S., Gasser, R., Prevost, J., Beaudoin-Bussieres, G., Anand, S. P., Laumaea, A., Grover, J. R., Lihong, L., Ho, D. D., Mascola, J., Finzi, A., Kwong, P. D., Blanchard, S. C., Mothes, W.
10.1101/2020.09.10.286948 — Posted: 2020-09-10
Epigenetic Evolution of ACE2 and IL-6 Genes as Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates
Sang, E. R., Tian, Y., Gong, Y., Miller, L. C., Sang, Y.
10.1101/2020.09.09.273268 — Posted: 2020-09-10
Molecular basis for SARS-CoV-2 spike affinity for human ACE2 receptor
Delgado, J. M., Duro, N., Rogers, D. M., Tkatchenko, A., Pandit, S. A., Varma, S.
10.1101/2020.09.10.291757 — Posted: 2020-09-10
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
Greaney, A. J., Starr, T. N., Gilchuk, P., Zost, S. J., Binshtein, E., Loes, A. N., Hilton, S. K., Huddleston, J., Eguia, R., Crawford, K. H., Dingens, A. S., Nargi, R. S., Sutton, R. E., Suryadevara, N., Rothlauf, P. W., Liu, Z., Whelan, S. P., Carnahan, R. H., Crowe, J. E., Bloom, J. D.
10.1101/2020.09.10.292078 — Posted: 2020-09-10 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).